Drugs Made In America Acquisition II Ord Shs
DMII9.990USD
+0.030+0.30%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
655.09M시가총액
--P/E TTM
자세한 내용은 Drugs Made In America Acquisition II Ord Shs 회사
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Ord Shs 정보
종목 코드 DMII
회사 이름Drugs Made In America Acquisition II Corp
상장일Sep 25, 2025
CEOStockwell (Lynn)
직원 수- -
유형Ordinary Share
회계 연도 종료- -
주소1 East Broward Boulevard
도시FT LAUDERDALE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33301
전화19548703099
웹사이트
종목 코드 DMII
상장일Sep 25, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition II Ord Shs의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
Drugs Made In America Acquisition II LLC
7.37%
Conaway (Charles C.)
3.05%
MAABS, LLC
2.03%
King (Michael)
2.03%
Wolverine Asset Management, LLC
1.62%
기타
83.89%
주주
주주
비율
Drugs Made In America Acquisition II LLC
7.37%
Conaway (Charles C.)
3.05%
MAABS, LLC
2.03%
King (Michael)
2.03%
Wolverine Asset Management, LLC
1.62%
기타
83.89%
주주 유형
주주
비율
Corporation
9.40%
Individual Investor
8.23%
Investment Advisor
2.90%
Hedge Fund
1.62%
Investment Advisor/Hedge Fund
0.12%
기타
77.72%
기관 주식 보유
마지막 업데이트: Wed, Jan 21
마지막 업데이트: Wed, Jan 21
보고 기간
기관 수
보유 주식
비율
변동
2026Q4
1
666.67K
0.00%
--
2025Q4
5
1.84M
2.81%
+1.84M
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Drugs Made In America Acquisition II LLC
4.83M
7.37%
+4.83M
--
Dec 03, 2025
Conaway (Charles C.)
2.00M
3.05%
+2.00M
--
Dec 03, 2025
MAABS, LLC
1.33M
2.03%
+1.33M
--
Dec 03, 2025
King (Michael)
1.33M
2.03%
+1.33M
--
Dec 03, 2025
Robinson (Edward)
1.00M
1.52%
+1.00M
--
Dec 03, 2025
Jessnick Capital Management, LLC
666.67K
1.02%
+666.67K
--
Dec 03, 2025
Higbee (Tyler)
666.67K
1.02%
+666.67K
--
Dec 03, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
